Skip to main content
![Single-Time-Point Imaging for Dosimetry After [<sup>177</sup>Lu]Lu-DOTATATE: Accuracy of Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to Time-Point Selection](https://jnm.snmjournals.org/sites/default/files/styles/medium/public/externals/d7db4cd18b1d25f0e05123c2f192ce60.jpg?itok=ndBERhBj)
![[<sup>177</sup>Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement](https://jnm.snmjournals.org/sites/default/files/styles/medium/public/externals/52b4018df3971d4e4a310e3f5774af8d.jpg?itok=pjUFKQ1n)
![<sup>64</sup>Cu Treatment Planning and <sup>67</sup>Cu Therapy with Radiolabeled [<sup>64</sup>Cu/<sup>67</sup>Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry](https://jnm.snmjournals.org/sites/default/files/styles/medium/public/externals/03137eb209dae5fcc2c83c9fb87781e4.jpg?itok=5LZUxZza)
